Supporting women through opioid dependence treatment in…
A study in the Medical Journal of Australia highlights the importance of supporting pregnant women with opioid dependence through methadone and buprenorphine treatment. It calls for better data collection to improve clinical outcomes and service delivery.
Why it matters
Improving treatment retention for opioid-dependent pregnant women is vital for the health and development of both the mother and the child.
Most women with opioid dependence engage in treatment and remain engaged in treatment during and after pregnancy, but some may need additional support to remain in treatment.
The article is a summary of medical research and public health policy recommendations.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in